Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis.

Burnett RS, Clohisy JC, Wright RW, McDonald DJ, Shively RA, Givens SA, Barrack RL.

J Arthroplasty. 2007 Apr;22(3):317-24.

PMID:
17400085
2.

Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty.

White RH, Romano PS, Zhou H, Rodrigo J, Bargar W.

Arch Intern Med. 1998 Jul 27;158(14):1525-31.

PMID:
9679793
3.

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement.

Agnelli G, Haas S, Ginsberg JS, Krueger KA, Dmitrienko A, Brandt JT.

J Thromb Haemost. 2007 Apr;5(4):746-53.

4.

Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty.

Lachiewicz PF.

Orthopedics. 2009 Dec;32(12 Suppl):74-8. doi: 10.3928/01477447-20091103-52.

PMID:
20201480
5.
6.

Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty.

Nerurkar J, Wade WE, Martin BC.

Pharmacotherapy. 2002 Aug;22(8):990-1000. Review.

PMID:
12173802
7.

VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty.

Westrich GH, Bottner F, Windsor RE, Laskin RS, Haas SB, Sculco TP.

J Arthroplasty. 2006 Sep;21(6 Suppl 2):139-43.

PMID:
16950076
8.

A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).

Turpie AG, Bauer KA, Davidson BL, Fisher WD, Gent M, Huo MH, Sinha U, Gretler DD; EXPERT Study Group.

Thromb Haemost. 2009 Jan;101(1):68-76.

PMID:
19132191
9.

The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty.

Pellegrini VD Jr, Donaldson CT, Farber DC, Lehman EB, Evarts CM.

Clin Orthop Relat Res. 2006 Nov;452:21-7.

PMID:
16906107
10.

Managing thromboembolic risk in hip and knee arthroplasty: state of the art.

Colwell CW Jr.

Orthopedics. 2003 Feb;26(2 Suppl):s231-6. Review.

PMID:
12597231
11.

Venous thromboembolic disease after total hip and knee arthroplasty.

Haas SB, Barrack RL, Westrich G.

Instr Course Lect. 2009;58:781-93.

PMID:
19385586
12.

Venous thromboembolism: management by American Association of Hip and Knee Surgeons.

Markel DC, York S, Liston MJ Jr, Flynn JC, Barnes CL, Davis CM 3rd; AAHKS Research Committee.

J Arthroplasty. 2010 Jan;25(1):3-9.e1-2. doi: 10.1016/j.arth.2009.07.021. Epub 2009 Oct 17.

PMID:
19837560
13.
14.

[Venous thromboembolism prophylaxis in major orthopaedic surgery: A multicenter, prospective, observational study].

Altintaş F, Gürbüz H, Erdemli B, Atilla B, Ustaoğlu RG, Oziç U, Savk O, Bayram H, Memik R, Akgün I, Göğüş A, Pestilci F, Konal A, Argün M, Oztürk I, Dabak N, Bilgen OF, Serin E, Onder C, Simşek A, Tözün R, Kinik H.

Acta Orthop Traumatol Turc. 2008 Nov-Dec;42(5):322-7. Turkish.

15.

Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol.

Beksaç B, González Della Valle A, Anderson J, Sharrock NE, Sculco TP, Salvato EA.

Clin Orthop Relat Res. 2007 Oct;463:114-9.

PMID:
17960674
16.

High incidence of complications from enoxaparin treatment after arthroplasty.

Neviaser AS, Chang C, Lyman S, Della Valle AG, Haas SB.

Clin Orthop Relat Res. 2010 Jan;468(1):115-9. doi: 10.1007/s11999-009-1020-6. Epub 2009 Aug 11.

17.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
18.

Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.

Pellegrini VD Jr, Sharrock NE, Paiement GD, Morris R, Warwick DJ.

Instr Course Lect. 2008;57:637-61. Review.

PMID:
18399613
19.

Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty.

Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA, Parvizi J, Pellegrini V, Stringer TA, Tornetta P 3rd, Haralson RH 3rd, Watters WC 3rd.

J Am Acad Orthop Surg. 2009 Mar;17(3):183-96.

PMID:
19264711
20.

The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.

Chotanaphuti T, Ongnamthip P, Silpipat S, Foojareonyos T, Roschan S, Reumthantong A.

J Med Assoc Thai. 2007 Jul;90(7):1342-7.

PMID:
17710975

Supplemental Content

Support Center